EcoDrugPlus

Aurora Kinase C

Ensembl ID : ENSCAFG00020015076
Gene Symbol: AURKC
3 Cross references
99 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSCAFG00020001856
Gene Symbol: BACE1
3 Cross references
220 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSCAFG00020014199
Gene Symbol: BDKRB1
3 Cross references
149 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSCAFG00020014203
Gene Symbol: BDKRB2
3 Cross references
362 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSCAFG00020021214
Gene Symbol: BCHE
3 Cross references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSCAFG00020008528
Gene Symbol: CALCRL
3 Cross references
149 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSCAFG00020005795
Gene Symbol: CASR
3 Cross references
203 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSCAFG00020020509
Gene Symbol: CACNA2D1
3 Cross references
287 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSCAFG00020022192
Gene Symbol: CACNA2D2
3 Cross references
269 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 4

Ensembl ID : ENSCAFG00020012026
Gene Symbol: CACNA2D4
1 Cross references
313 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Beta 2

Ensembl ID : ENSCAFG00020009860
Gene Symbol: CACNB2
3 Cross references
206 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Beta 3

Ensembl ID : ENSCAFG00020013365
Gene Symbol: CACNB3
3 Cross references
278 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).